NYSTATIN, TRIAMCINOLONE ACETONIDE

NYSTATIN, TRIAMCINOLONE ACETONIDE was reported 109 times

These side effects are most commonly reported by patients taking NYSTATIN, TRIAMCINOLONE ACETONIDE:

# Side effect Count
0 DRUG INEFFECTIVE 23
1 PRODUCT USE IN UNAPPROVED INDICATION 11
2 APPLICATION SITE PAIN 8
3 PRURITUS 8
4 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6
5 DIARRHOEA 5
6 OFF LABEL USE 5
7 PAIN 5
8 RASH 5
9 ACCIDENTAL EXPOSURE TO PRODUCT 4
10 APPLICATION SITE PRURITUS 4
11 BURNING SENSATION 4
12 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4
13 FATIGUE 4
14 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
15 NAUSEA 4
16 URINARY TRACT INFECTION 4
17 WEIGHT DECREASED 4
18 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4
19 APPLICATION SITE ERYTHEMA 3
20 CONDITION AGGRAVATED 3
21 EXPIRED PRODUCT ADMINISTERED 3
22 HEADACHE 3
23 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3
24 INSOMNIA 3
25 JOINT SWELLING 3
26 PRODUCT CONTAINER ISSUE 3
27 PRODUCT QUALITY ISSUE 3
28 VOMITING 3
29 ABDOMINAL DISCOMFORT 2
30 APPLICATION SITE IRRITATION 2
31 BLOOD CHOLESTEROL INCREASED 2
32 BLOOD GLUCOSE INCREASED 2
33 CHEST PAIN 2
34 DEPRESSION 2
35 DIZZINESS 2
36 DRUG EFFECT DECREASED 2
37 DRY SKIN 2
38 DYSGEUSIA 2
39 ERYTHEMA 2
40 EYE IRRITATION 2
41 FUNGAL INFECTION 2
42 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2
43 INCORRECT DRUG ADMINISTRATION DURATION 2
44 INTENTIONAL PRODUCT USE ISSUE 2
45 KIDNEY INFECTION 2
46 MALAISE 2
47 MUSCLE SPASMS 2
48 NO ADVERSE EVENT 2
49 PERIPHERAL SWELLING 2
50 PRODUCT DISPENSING ERROR 2
51 PRODUCT PHYSICAL CONSISTENCY ISSUE 2
52 RASH ERYTHEMATOUS 2
53 SKIN EXFOLIATION 2
54 SKIN IRRITATION 2
55 SWELLING FACE 2
56 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
57 THERAPEUTIC RESPONSE UNEXPECTED 2
58 ABDOMINAL PAIN 1
59 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1
60 ACTIVITIES OF DAILY LIVING IMPAIRED 1
61 ACUTE MYOCARDIAL INFARCTION 1
62 AFFECT LABILITY 1
63 AGITATION 1
64 ALANINE AMINOTRANSFERASE INCREASED 1
65 ALBUMIN GLOBULIN RATIO DECREASED 1
66 ALLERGIC REACTION TO EXCIPIENT 1
67 ANAEMIA 1
68 ANAPHYLACTIC REACTION 1
69 ANORECTAL DISCOMFORT 1
70 ANTISOCIAL BEHAVIOUR 1
71 APPLICATION SITE DISCOLOURATION 1
72 APPLICATION SITE HAEMORRHAGE 1
73 APPLICATION SITE RASH 1
74 APPLICATION SITE VESICLES 1
75 ASPARTATE AMINOTRANSFERASE INCREASED 1
76 ASTHENIA 1
77 ATRIAL FIBRILLATION 1
78 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 1
79 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1
80 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1
81 BACK PAIN 1
82 BACTERIAL TEST POSITIVE 1
83 BACTERIAL VAGINOSIS 1
84 BLOOD ALBUMIN DECREASED 1
85 BLOOD BILIRUBIN INCREASED 1
86 BLOOD CHLORIDE INCREASED 1
87 BLOOD CREATININE DECREASED 1
88 BLOOD GLUCOSE DECREASED 1
89 BLOOD IRON INCREASED 1
90 BLOOD LACTATE DEHYDROGENASE INCREASED 1
91 BLOOD LACTIC ACID INCREASED 1
92 BLOOD POTASSIUM DECREASED 1
93 BLOOD POTASSIUM INCREASED 1
94 BLOOD PRESSURE ABNORMAL 1
95 BLOOD PRESSURE INCREASED 1
96 BLOOD UREA INCREASED 1
97 BLOOD URINE PRESENT 1
98 BORDERLINE GLAUCOMA 1
99 BREAST TENDERNESS 1
100 BRONCHIAL HYPERACTIVITY 1
101 C-REACTIVE PROTEIN INCREASED 1
102 CARBON DIOXIDE DECREASED 1
103 CARDIAC FAILURE CONGESTIVE 1
104 CARDIO-RESPIRATORY ARREST 1
105 CARDIOMYOPATHY 1
106 CELLULITIS 1
107 CEREBROVASCULAR ACCIDENT 1
108 CERVIX CARCINOMA 1
109 CHEILITIS 1
110 CHILLS 1
111 CHROMATURIA 1
112 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
113 COGNITIVE DISORDER 1
114 CONFUSIONAL STATE 1
115 CONSTIPATION 1
116 CONTRACEPTION 1
117 CONTRAINDICATED PRODUCT ADMINISTERED 1
118 CORONARY ARTERY DISEASE 1
119 COVID-19 1
120 CSF CELL COUNT INCREASED 1
121 CSF TEST ABNORMAL 1
122 CULTURE URINE POSITIVE 1
123 CYSTITIS 1
124 DECUBITUS ULCER 1
125 DELIRIUM 1
126 DERMATITIS 1
127 DERMATITIS ALLERGIC 1
128 DERMATITIS ATOPIC 1
129 DISEASE RECURRENCE 1
130 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1
131 DRUG INTERACTION 1
132 DRUG PRESCRIBING ERROR 1
133 DYSARTHRIA 1
134 DYSPHAGIA 1
135 DYSPHONIA 1
136 DYSPNOEA 1
137 ECZEMA 1
138 ENDOMETRIAL HYPERTROPHY 1
139 ENTEROBACTER PNEUMONIA 1
140 EOSINOPHIL PERCENTAGE DECREASED 1
141 EOSINOPHIL PERCENTAGE INCREASED 1
142 EYE PAIN 1
143 FEELING ABNORMAL 1
144 FLATULENCE 1
145 FREQUENT BOWEL MOVEMENTS 1
146 GAIT DISTURBANCE 1
147 GASTRIC DISORDER 1
148 GASTROINTESTINAL PAIN 1
149 GENITAL INJURY 1
150 GROIN PAIN 1
151 HAEMATOCHEZIA 1
152 HAEMATOCRIT DECREASED 1
153 HAEMOGLOBIN ABNORMAL 1
154 HAEMOLYSIS 1
155 HAEMORRHAGE 1
156 HAEMOTHORAX 1
157 HAPTOGLOBIN DECREASED 1
158 HEAD DISCOMFORT 1
159 HYPOACUSIS 1
160 HYPOAESTHESIA 1
161 HYPOKALAEMIA 1
162 HYPONATRAEMIA 1
163 ILLNESS 1
164 IMMUNODEFICIENCY 1
165 INCORRECT DOSE ADMINISTERED 1
166 INCORRECT PRODUCT ADMINISTRATION DURATION 1
167 INCORRECT PRODUCT STORAGE 1
168 INCORRECT ROUTE OF DRUG ADMINISTRATION 1
169 INFECTION 1
170 INFLAMMATION 1
171 INFLUENZA 1
172 LIMB INJURY 1
173 LIP DRY 1
174 LIP EXFOLIATION 1
175 LOSS OF LIBIDO 1
176 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
177 LYMPHOCYTE COUNT DECREASED 1
178 LYMPHOCYTE PERCENTAGE DECREASED 1
179 LYMPHOMA 1
180 MEAN CELL HAEMOGLOBIN DECREASED 1
181 MEAN PLATELET VOLUME DECREASED 1
182 MEDIASTINAL INFECTION 1
183 MEDICATION ERROR 1
184 MENSTRUATION IRREGULAR 1
185 MIDDLE EAR EFFUSION 1
186 MIGRAINE 1
187 MITRAL VALVE INCOMPETENCE 1
188 MONOCYTE COUNT DECREASED 1
189 MONOCYTE PERCENTAGE INCREASED 1
190 MUSCLE SPASTICITY 1
191 MYOCARDIAL ISCHAEMIA 1
192 NEPHROLITHIASIS 1
193 NEURALGIA 1
194 NEUROGENIC BLADDER 1
195 NEUTROPHIL COUNT INCREASED 1
196 NEUTROPHIL PERCENTAGE INCREASED 1
197 NITRITE URINE PRESENT 1
198 NUCLEATED RED CELLS 1
199 OEDEMA PERIPHERAL 1
200 ONYCHOMYCOSIS 1
201 OPEN ANGLE GLAUCOMA 1
202 OROPHARYNGEAL PAIN 1
203 OSTEOPENIA 1
204 OSTEOPOROSIS 1
205 OVARIAN CYST 1
206 OVARIAN CYST RUPTURED 1
207 PAIN IN JAW 1
208 PAINFUL ERECTION 1
209 PARAPLEGIA 1
210 PENILE PAIN 1
211 PERFUME SENSITIVITY 1
212 PHARMACEUTICAL PRODUCT COMPLAINT 1
213 PLANTAR FASCIITIS 1
214 PLATELET COUNT INCREASED 1
215 PLEURAL EFFUSION 1
216 PNEUMONIA 1
217 PNEUMONIA KLEBSIELLA 1
218 POLYCHROMASIA 1
219 POOR QUALITY PRODUCT ADMINISTERED 1
220 POST THROMBOTIC SYNDROME 1
221 POSTURING 1
222 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
223 PRODUCT ADMINISTRATION ERROR 1
224 PRODUCT CLOSURE ISSUE 1
225 PRODUCT DESIGN ISSUE 1
226 PRODUCT DOSE OMISSION 1
227 PRODUCT LABEL ISSUE 1
228 PRODUCT PACKAGING DIFFICULT TO OPEN 1
229 PRODUCT PRESCRIBING ISSUE 1
230 PRODUCT SELECTION ERROR 1
231 PRODUCT STORAGE ISSUE 1
232 PRODUCT SUBSTITUTION ISSUE 1
233 PROTEIN URINE PRESENT 1
234 PROTHROMBIN TIME PROLONGED 1
235 PYELONEPHRITIS 1
236 PYREXIA 1
237 RADICULOPATHY 1
238 RED BLOOD CELL COUNT DECREASED 1
239 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
240 RED BLOOD CELLS URINE POSITIVE 1
241 RED CELL DISTRIBUTION WIDTH INCREASED 1
242 RENAL FAILURE 1
243 RETICULOCYTE COUNT INCREASED 1
244 RETICULOCYTE PERCENTAGE INCREASED 1
245 RHINITIS ALLERGIC 1
246 ROTATOR CUFF SYNDROME 1
247 SERUM FERRITIN INCREASED 1
248 SINUSITIS 1
249 SKIN ABRASION 1
250 SKIN CANCER 1
251 SKIN DISORDER 1
252 SKIN FISSURES 1
253 SKIN LACERATION 1
254 STEROID WITHDRAWAL SYNDROME 1
255 STICKY SKIN 1
256 SUPRAVENTRICULAR EXTRASYSTOLES 1
257 SUPRAVENTRICULAR TACHYCARDIA 1
258 SUSPECTED PRODUCT CONTAMINATION 1
259 SYNCOPE 1
260 THERAPEUTIC PRODUCT EFFECT INCREASED 1
261 THERAPY INTERRUPTED 1
262 TINEA CRURIS 1
263 TOOTHACHE 1
264 TRANSFERRIN SATURATION INCREASED 1
265 TRANSIENT ISCHAEMIC ATTACK 1
266 TREMOR 1
267 URINARY CASTS 1
268 URINARY INCONTINENCE 1
269 URINARY SEDIMENT PRESENT 1
270 URINE ANALYSIS ABNORMAL 1
271 URINE LEUKOCYTE ESTERASE POSITIVE 1
272 UROBILINOGEN URINE INCREASED 1
273 UTERINE HAEMORRHAGE 1
274 VAGINAL DISCHARGE 1
275 VAGINAL HAEMORRHAGE 1
276 VAGINAL INFECTION 1
277 VASCULAR INSUFFICIENCY 1
278 VISION BLURRED 1
279 VITAMIN C ABNORMAL 1
280 VITAMIN D DEFICIENCY 1
281 VULVAL DISORDER 1
282 VULVOVAGINAL CANDIDIASIS 1
283 VULVOVAGINAL PAIN 1
284 VULVOVAGINAL PRURITUS 1
285 WEIGHT INCREASED 1
286 WHITE BLOOD CELLS URINE POSITIVE 1
287 WOUND 1
288 WRONG DRUG ADMINISTERED 1
289 WRONG PRODUCT ADMINISTERED 1